These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25973526)

  • 1. Fixed-Dose Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: Results of a Randomized, Placebo-Controlled Study and Open-Label Extension.
    Bull J; Wellman CV; Israel RJ; Barrett AC; Paterson C; Forbes WP
    J Palliat Med; 2015 Jul; 18(7):593-600. PubMed ID: 25973526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Tolerability of Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: A Responder Analysis of 2 Randomized, Placebo-Controlled Trials.
    Nalamachu SR; Pergolizzi J; Taylor R; Slatkin NE; Barrett AC; Yu J; Bortey E; Paterson C; Forbes WP
    Pain Pract; 2015 Jul; 15(6):564-71. PubMed ID: 24815199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylnaltrexone for opioid-induced constipation in patients with advanced illness: a 3-month open-label treatment extension study.
    Lipman AG; Karver S; Cooney GA; Stambler N; Israel RJ
    J Pain Palliat Care Pharmacother; 2011; 25(2):136-45. PubMed ID: 21657861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients With Chronic Noncancer Pain: A Placebo Crossover Analysis.
    Viscusi ER; Barrett AC; Paterson C; Forbes WP
    Reg Anesth Pain Med; 2016; 41(1):93-8. PubMed ID: 26650429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled study.
    Michna E; Blonsky ER; Schulman S; Tzanis E; Manley A; Zhang H; Iyer S; Randazzo B
    J Pain; 2011 May; 12(5):554-62. PubMed ID: 21429809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, Double-Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain.
    Rauck R; Slatkin NE; Stambler N; Harper JR; Israel RJ
    Pain Pract; 2017 Jul; 17(6):820-828. PubMed ID: 27860208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous methylnaltrexone for treatment of acute opioid-induced constipation: phase 2 study in rehabilitation after orthopedic surgery.
    Anissian L; Schwartz HW; Vincent K; Vincent HK; Carpenito J; Stambler N; Ramakrishna T
    J Hosp Med; 2012 Feb; 7(2):67-72. PubMed ID: 21998076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of subcutaneous methylnaltrexone in the treatment of opioid-induced constipation: a responder post hoc analysis.
    Michna E; Weil AJ; Duerden M; Schulman S; Wang W; Tzanis E; Zhang H; Yu D; Manley A; Randazzo B
    Pain Med; 2011 Aug; 12(8):1223-30. PubMed ID: 21810165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylnaltrexone for opioid-induced constipation in advanced illness.
    Thomas J; Karver S; Cooney GA; Chamberlain BH; Watt CK; Slatkin NE; Stambler N; Kremer AB; Israel RJ
    N Engl J Med; 2008 May; 358(22):2332-43. PubMed ID: 18509120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study.
    Portenoy RK; Thomas J; Moehl Boatwright ML; Tran D; Galasso FL; Stambler N; Von Gunten CF; Israel RJ
    J Pain Symptom Manage; 2008 May; 35(5):458-68. PubMed ID: 18440447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness.
    Chamberlain BH; Cross K; Winston JL; Thomas J; Wang W; Su C; Israel RJ
    J Pain Symptom Manage; 2009 Nov; 38(5):683-90. PubMed ID: 19713070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylnaltrexone Versus Naloxone for Opioid-Induced Constipation in the Medical Intensive Care Unit.
    Merchan C; Altshuler D; Papadopoulos J
    Ann Pharmacother; 2017 Mar; 51(3):203-208. PubMed ID: 28168885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-Dose Efficacy of Methylnaltrexone in Patients with Severe Medical Illness and Opioid-Induced Constipation: A Pooled Analysis.
    Peacock WF; Slatkin NE; Israel RJ; Stambler N
    J Emerg Med; 2022 Feb; 62(2):231-239. PubMed ID: 34893381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of opioid receptor antagonists in the treatment of opioid-induced constipation: a review.
    Leppert W
    Adv Ther; 2010 Oct; 27(10):714-30. PubMed ID: 20799006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of subcutaneous methylnaltrexone on patient-reported constipation symptoms.
    Iyer SS; Randazzo BP; Tzanis EL; Schulman SL; Zhang H; Wang W; Manley AL
    Value Health; 2011 Jan; 14(1):177-83. PubMed ID: 21211500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylnaltrexone: MNTX.
    Drugs R D; 2006; 7(6):374-8. PubMed ID: 17073520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review.
    Mehta N; O'Connell K; Giambrone GP; Baqai A; Diwan S
    Postgrad Med; 2016; 128(3):282-9. PubMed ID: 26839023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients.
    Slatkin N; Thomas J; Lipman AG; Wilson G; Boatwright ML; Wellman C; Zhukovsky DS; Stephenson R; Portenoy R; Stambler N; Israel R
    J Support Oncol; 2009; 7(1):39-46. PubMed ID: 19278178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylnaltrexone bromide for the treatment of opioid-induced constipation in patients with advanced illness--a cost-effectiveness analysis.
    Earnshaw SR; Klok RM; Iyer S; McDade C
    Aliment Pharmacol Ther; 2010 Apr; 31(8):911-21. PubMed ID: 20096019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer.
    Janku F; Johnson LK; Karp DD; Atkins JT; Singleton PA; Moss J
    Ann Oncol; 2016 Nov; 27(11):2032-2038. PubMed ID: 27573565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.